FREDUNPHARMACEUTICALS / FY26 summary

The year in one view.

Fredun Pharmaceuticals · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

374

₹ Cr where applicable

PAT across quarters

21.1

₹ Cr where applicable

Source quarters

2

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 26.3 · Positive source sentiment · 2026-02-14Q3 FY26Q4 FY26: 29.1 · Positive source sentiment · 2026-05-15Q4 FY2629.126.3
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.